Date |
Title |
Lab/Clinic |
Presenter |
---|
Dec 17, 2003
|
Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, Hulsbergen van de Kaa C, de la Rosette Jean, and Weissleder R. Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer. N Engl J Med 2003 June;348:2491-9. |
|
|
Dec 10, 2003 |
Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ. Local gene knockdown in the brain using viral-mediated RNA interference.Nat Med. 2003 Dec;9(12):1539-44. |
|
|
Dec 3, 2003
|
Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med. 2003 Nov;44(11):1797-803. |
|
|
Nov 26, 2003
|
Miyagawa T, Oku T, Sasajima T, Dasai R, Beattie B, Finn R, Tjuvajev JG, Blasberg R. Assessment of Treatment Response by Autoradiography with (14)C-Aminocyclopentane Carboxylic Acid, (67)Ga-DTPA, and (18)F-FDG in a Herpes Simplex Virus Thymidine Kinase/Ganciclovir Brain Tumor Model. J Nucl Med. 2003 Nov;44(11):1845-1854. |
|
|
Nov 12, 2003
|
Wang J, Chen P, Mrkobrada M, Hu M, Vallis KA, Reilly RM. Antisense imaging of epidermal growth factor-induced p21 (WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts. Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1273-80. Epub 2003 Mar 15. |
|
|
Nov 5, 2003
|
Burggasser G, Hurtl I, Hauff W, Lukas J, Greifeneder M, Heydari B, Thaler A, Wedrich A, Virgolini I. Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease. J Nucl Med. 2003 Oct;44(10):1547-55. |
|
|
Oct 29, 2003 |
Doubrovin M, Ponomarev V, Serganova I, Soghomonian S, Myagawa T, Beresten T, Ageyeva L, Sadelain M, Koutcher J, Blasberg RG, Tjuvajev JG. Development of a new reporter gene system--dsRed/xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrier. Mol Imaging. 2003 Apr;2(2):93-112. |
|
|
Oct 22, 2003 |
Luster M, Sherman SI, Skarulis MC, Reynolds JR, Lassmann M, Hanscheid H, Reiners C.Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1371-7. Epub 2003 Jul 15. |
|
|
Oct 15, 2003
|
Lee KH, Byun SS, Paik JY, Lee SY, Song SH, Choe YS, Kim BT.Cell uptake and tissue distribution of radioiodine labelled D-luciferin: implications for luciferase based gene imaging. Nucl Med Commun. 2003 Sep;24(9):1003-9. |
|
|
Oct 8, 2003 |
Duff S, et al. CD105 is important for angiogenesis: evidence and potential applications. FASEB Journal 2003;17:984-992. |
|
|
Oct 1, 2003 |
Bredow S, et al. Imaging of tumour neovasculature by targeting the TGF-B binding receptor endoglin. European Journal of Cancer 2000;36:675-681. |
|
|
Sept 24, 2003 |
Buck K, et al. Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG. Journal Nuclear Medicine 2003;44:426-1431. |
|
|
Sept 17, 2003 |
Freedman N T M, et al. Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans. European Journal Nuclear Medicine 2003;30:46-53. |
|
|
Aug 20, 2003 |
Bird N J, et al. Indexing Glomerular Filtration Rate to Suit Children. Journal Nuclear Medicine 2003;44:1037-1043. |
|
|
Aug 13, 2003 |
Hickeson M, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG_PET. European Journal Nuclear Medicine 2003;29:1639-1647. |
|
|
July 16, 2003 |
Johansson L, et al. Hormesis, an update of the present position. European Journal Nuclear Medicine Imaging 2003;30:921-933. |
|
|
July9, 2003 |
Karam M, et al. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Nuclear Medicine Communications 2003;24:489-495. |
|
|